Correlation Between KORE Group and AN2 Therapeutics

Can any of the company-specific risk be diversified away by investing in both KORE Group and AN2 Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining KORE Group and AN2 Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between KORE Group Holdings and AN2 Therapeutics, you can compare the effects of market volatilities on KORE Group and AN2 Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in KORE Group with a short position of AN2 Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of KORE Group and AN2 Therapeutics.

Diversification Opportunities for KORE Group and AN2 Therapeutics

-0.05

Correlation Coefficient

KORE Group  AN2 Therapeutics

Good diversification

The 3 months correlation between KORE and AN2 is -0.05. Overlapping area represents the amount of risk that can be diversified away by holding KORE Group Holdings and AN2 Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on AN2 Therapeutics and KORE Group is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on KORE Group Holdings are associated (or correlated) with AN2 Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of AN2 Therapeutics has no effect on the direction of KORE Group i.e., KORE Group and AN2 Therapeutics go up and down completely randomly.

Pair Corralation between KORE Group and AN2 Therapeutics

Given the investment horizon of 90 days KORE Group Holdings is expected to generate 2.05 times more return on investment than AN2 Therapeutics. However, KORE Group is 2.05 times more volatile than AN2 Therapeutics. It trades about 0.04 of its potential returns per unit of risk. AN2 Therapeutics is currently generating about 0.02 per unit of risk. If you would invest  244.00  in KORE Group Holdings on December 27, 2024 and sell it today you would earn a total of  7.00  from holding KORE Group Holdings or generate 2.87% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

KORE Group Holdings  vs.  AN2 Therapeutics

KORE Group Holdings

Risk-Adjusted Performance

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in KORE Group Holdings are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of rather conflicting basic indicators, KORE Group exhibited solid returns over the last few months and may actually be approaching a breakup point.

AN2 Therapeutics

Risk-Adjusted Performance

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in AN2 Therapeutics are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of fairly strong basic indicators, AN2 Therapeutics is not utilizing all of its potentials. The latest stock price disturbance, may contribute to short-term losses for the investors.

Pair Trading with KORE Group and AN2 Therapeutics

The main advantage of trading using opposite KORE Group and AN2 Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if KORE Group position performs unexpectedly, AN2 Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in AN2 Therapeutics will offset losses from the drop in AN2 Therapeutics' long position.

The idea behind KORE Group Holdings and AN2 Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.